(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 86.59%-10.51K | 107.88%1.5K | 90.75%-3.1K | 62.27%-887 | 65.77%-8.03K | 54.35%-78.4K | 79.68%-19.06K | -391.24%-33.54K | 96.92%-2.35K | -80.40%-23.45K |
Net income from continuing operations | 79.37%-197.16K | 87.59%-104.13K | -16.87%-33.6K | -608.62%-23.48K | 61.14%-35.95K | -1,436.63%-955.92K | -309.65%-839.28K | 74.73%-28.75K | 104.19%4.62K | 11.69%-92.51K |
Operating gains losses | 1,306.06%7.42K | -77.97%2.41K | 145.60%5.47K | 27.86%-5.02K | -46.49%4.56K | 100.12%528 | --10.96K | ---11.99K | ---6.96K | --8.52K |
Asset impairment expenditure | -100.00%1 | ---- | ---- | ---- | ---- | --765.54K | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | -75.00%4.5K | --0 | --0 | --0 | -88.89%4.5K | -32.73%18K | --0 | --0 | ---22.5K | --40.5K |
Other non cashItems | -14.52%21.41K | 5.23%5.33K | -25.75%5.35K | -15.39%5.43K | -16.65%5.3K | 316.72%25.05K | --5.07K | --7.21K | --6.41K | --6.36K |
Change In working capital | 124.13%153.31K | 153.27%97.89K | --19.68K | 38.03%22.19K | -0.88%13.56K | -6.63%68.4K | 121.22%38.65K | --0 | -52.55%16.08K | -85.09%13.68K |
-Change in receivables | 428.33%45.51K | 596.03%52.78K | ---2.54K | -333.40%-2.23K | 7.47%-2.5K | -143.23%-13.86K | 11.96%-10.64K | --0 | 0.96%-515 | -105.59%-2.7K |
-Change in payables and accrued expense | 31.05%107.8K | -8.49%45.1K | --22.22K | 47.20%24.42K | -1.97%16.06K | 99.67%82.26K | 143.73%49.29K | --0 | -55.58%16.59K | -62.27%16.38K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 86.59%-10.51K | 107.88%1.5K | 90.75%-3.1K | 62.27%-887 | 65.77%-8.03K | 54.35%-78.4K | 79.68%-19.06K | -391.24%-33.54K | 96.92%-2.35K | -80.40%-23.45K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -5.29K | -1.59K | 0 | 0 | -3.7K | 0 | 0 | 0 | 0 | 0 |
Net PPE purchase and sale | ---5.29K | ---1.59K | --0 | --0 | ---3.7K | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---5.29K | ---1.59K | --0 | --0 | ---3.7K | --0 | --0 | --0 | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -98.25%1.2K | 0 | 0 | -44.06%68.42K | -48.34%67.92K | 0 | ||||
Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | -44.31%68.12K | ---- | ---- | ---- | ---- |
Net other financing activities | 300.00%1.2K | --0 | --0 | ---- | ---- | --300 | ---200 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -98.25%1.2K | --0 | --0 | ---- | ---- | -44.06%68.42K | -48.34%67.92K | --0 | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -39.37%15.38K | 102.57%859 | 6,501.67%3.96K | 90.89%3.65K | -39.37%15.38K | -78.20%25.36K | -727.01%-33.48K | -99.65%60 | -98.15%1.91K | -78.20%25.36K |
Current changes in cash | -46.28%-14.61K | -100.18%-90 | 90.75%-3.1K | 116.91%313 | 49.99%-11.73K | 89.02%-9.99K | 144.00%48.85K | -187.76%-33.54K | 97.86%-1.85K | -80.40%-23.45K |
End cash Position | -95.00%769 | -95.00%769 | 102.57%859 | 6,501.67%3.96K | 90.89%3.65K | -39.37%15.38K | -39.37%15.38K | -727.01%-33.48K | -99.65%60 | -98.15%1.91K |
Free cash from | 79.84%-15.81K | 99.53%-90 | 90.75%-3.1K | 62.27%-887 | 49.99%-11.73K | 60.86%-78.4K | 80.65%-19.06K | -438.04%-33.54K | 97.15%-2.35K | -80.40%-23.45K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data